This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

I. An Analysis of the Major Manifestations Observed, the Factors Involved in Its Occurrence and the Cardiac Residua

COMMANDER ROBERT C. MANCHESTER, (MC) U.S.N.R.

Arch Intern Med. 1946;77(3):317-331.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

TWO hundred and twenty-one cases of rheumatic fever and rheumatic heart disease observed in this hospital have been analyzed in order to determine the significant factors involved in the occurrence of rheumatic fever in naval personnel, the clinical characteristics of the disease and the effectiveness of intensive salicylate therapy. The factors involved in its occurrence, the major manifestations observed and the incidence of permanent cardiac damage will be considered in this paper.

A significant difference exists between military and civilian population groups affected by rheumatic fever. The average age of onset in civilian life is 8 years, and 70 per cent of the persons affected have already acquired the disease by the age of 15.¹ A study of 1,000 cases followed for ten years by Bland and Jones² clearly indicates the outlook in this childhood group. The average age of onset was 8 years. Ten years later, at an average . . . [Full Text PDF of this Article]

Footnotes
This article has been released for publication by the Division of Publications of the Bureau of Medicine and Surgery of the United States Navy. The opinions and views set forth in this article are those of the writer and are not to be construed as reflecting the policies of the Navy Department.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?